PD-L1 scoring by CPS is being used in other cancer types such as head and neck squamous cell carcinoma and gastric carcinoma, on the basis of, among others, the results of the KEYNOTE-012 and KEYNOTE-055 studies, respectively.7 This evidence concerns the gene CD274 and cancer.